Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tumor Associated Macrophages, as the Dominant Immune Cells, Are an Indispensable Target for Immunologically Cold Tumor—Glioma Therapy?
Ni Tong, Zhenqiang He, Yujie Ma, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 62

Showing 51-75 of 62 citing articles:

Prognostic Impact of the Immune-Cell Infiltrate in N1-Positive Non–Small-Cell Lung Cancer
Florian Eichhorn, Andreas Weigert, Rajender Nandigama, et al.
Clinical Lung Cancer (2023) Vol. 24, Iss. 8, pp. 706-716.e1
Closed Access | Times Cited: 1
CD47 polymorphism for predicting nivolumab benefit in patients with advanced non‑small‑cell lung cancer
Tatsuya Ogimoto, Hiroaki Ozasa, Hironori Yoshida, et al.
Oncology Letters (2023) Vol. 26, Iss. 2
Open Access | Times Cited: 1
Screening of potential key genes in esophageal cancer based on RBP and expression verification of HENMT1
Abdusemer Reyimu, Fei Xing, Wubi Zhou, et al.
Medicine (2023) Vol. 102, Iss. 49, pp. e36544-e36544
Open Access | Times Cited: 1
The roles EpCAM plays to enhance the malignancy of gastric cancer
Xuewei Zhao, Ruixia Zhao, Feng Yang, et al.
Research Square (Research Square) (2023)
Open Access
The Evolving Landscape of Monocyte/Macrophage System in Glioma
Alessandra Maielli, Federica Mornata, Pasquale Persico, et al.
Interdisciplinary cancer research (2023)
Closed Access
Identified RP2 as a prognostic biomarker for glioma, facilitating glioma pathogenesis mainly via regulating tumor immunity
Yiyang Gong, Yun Ke, Zichuan Yu, et al.
Aging (2023) Vol. 15, Iss. 16, pp. 8155-8184
Open Access
Exploring potential therapeutic targets for glioma based on non-targeted metabolic analysis
Sibo Li, Xudong Jiang, Gang Chen, et al.
Research Square (Research Square) (2023)
Open Access
Immunological processes of enhancers and suppressors of long non-coding RNAs associated with brain tumors and inflammation
Hossein Tahmasebi Dehkordi, Fatemeh Khaledi, Sorayya Ghasemi
International Reviews of Immunology (2023) Vol. 43, Iss. 3, pp. 178-196
Closed Access
Innate immune responses in patients treated with SBRT irradiation enhances prostate cancer remissions
Amrita K. Cheema, Yaoxiang Li, Sean P. Collins, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
Current Overview on the Potency of Natural Products for Modulating Myeloid-derived Suppressor Cells Dependent Cold Tumors
Rama Rao Malla, Lalitha Pappu, Krishna Chaitanya Amajala, et al.
Current Medicinal Chemistry (2022) Vol. 29, Iss. 40, pp. 6197-6216
Closed Access
IL-10R Inhibition Reprograms Tumor-Associated Macrophages and Reverses Drug Resistance in Multiple Myeloma
Jennifer Sun, Barbara Muz, Katerina Miari, et al.
Research Square (Research Square) (2022)
Open Access
Role of Tumor Microenvironment in Cancer Stem Cell and Clinical Application
Angel Wang
American Journal of Biomedical Science & Research (2022) Vol. 15, Iss. 6, pp. 639-648
Open Access
Previous Page - Page 3

Scroll to top